Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
Developing a bedside genomic test for safer, paediatric antibiotic use. Our project aims to evaluate the role of genetic testing to prevent permanent drug-related hearing loss in children receiving aminoglycoside antibiotic treatment with a view to developing a rapid bedside, point-of-care
The study team is following the lives of over 1,200 Melbourne children from birth to primary school, exploring the immune boosting effects of Bacille Calmette-Guérin (BCG) vaccine and whether this vaccine can reduce the risk of infectious diseases, as well as food allergy, eczema and asthma in
EARSHOT Study is an international, multicentre prospective cohort study evaluating the risk of hearing loss in children receiving antibiotic treatment. We are improving paediatric care by predicting and preventing aminoglycoside antibiotic associated hearing damage.
On target, on time: advancing diagnosis for children with complicated pneumonia across Asia. Using molecular diagnostics to improve the detection of childhood lung infections, enabling better patient care and informing vaccine strategies across Asia.
The Melbourne ASSET score was designed to help clinicians decide whether to use intravenous or oral antibiotics for children with skin and soft tissue infections Skin infections are very common in children. In most cases, children can be treated with antibiotics taken by mouth but in some children,
Transforming understanding of infectious diseases into actionable solutions that protect lives today and strengthen resilience for the future. The Infection X Research Platform is a vital, innovative initiative born from lessons of the COVID-19 pandemic. It addresses the urgent need for a
Our work in the region includes social and behavioural research into vaccine uptake, vaccine resource development, and a vaccine education and communication training program.
Evaluating pneumococcal vaccines with specific antibody tests and bacteria-killing assays. We offer advanced tools to evaluate immune responses to pneumococcal vaccines, ensuring global standards.
This study will develop a reference atlas of healthy cells in the paediatric airway in order to understand the changes caused by childhood lung disease.
Understanding Pleural Empyema in children hospitalised in Melbourne, Australia, over an eight‑year period.
Page 37 of 188
